Ehrlich Christopher B
SEC insider (Form 3/4/5 filer). CIK 0001293973. Chairman and CEO at CERO THERAPEUTICS HOLDINGS, INC. (CERO). 7 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Ehrlich Christopher B has filed insider reports for
- CERO THERAPEUTICS HOLDINGS, INC. (CERO): Director, Officer, Chairman and CEO
Ehrlich Christopher B
CIK: 0001293973
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CERO THERAPEUTICS HOLDINGS, INC.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jan 7, 2026CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
4.5M shares- - May 30, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
61.8K shares- - Mar 4, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
119.5K shares- - Feb 24, 2025CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
1.3M shares- - Dec 2, 2024CERO
CERO THERAPEUTICS HOLDINGS, INC.
AwardDirectStock Option (Right to Buy)
1.3M shares- - Sep 30, 2024CERO
CERO THERAPEUTICS HOLDINGS, INC.
DispositionDirectStock Option (Right to Buy)
572.2K shares- - Sep 25, 2024CERO
CERO THERAPEUTICS HOLDINGS, INC.
ExerciseDirect5.3M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 4,530,997 | - | - | Direct |
| May 30, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 61,843 | - | - | Direct |
| Mar 4, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 119,486 | - | - | Direct |
| Feb 24, 2025 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 1,275,000 | - | - | Direct |
| Dec 2, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Award Stock Option (Right to Buy) | 1,275,000 | - | - | Direct |
| Sep 30, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Disposition Stock Option (Right to Buy) | 572,182 | - | - | Direct |
| Sep 25, 2024 | CERO CERO THERAPEUTICS HOLDINGS, INC. | Exercise | 5,312,983 | - | $0 | Direct |
1-7 of 7 transactions